Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Heart Will Be Treated With Custodioln

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Phase 2 (1)
Phase 2/3 (1)

Trial Status

Completed1
Suspended1
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07381530Phase 2SuspendedPrimary

Study of Cardioplegia in Cardiac Surgery Due to Congenital Heart Malformation in Children

NCT05101746Phase 2/3Enrolling By Invitation

Nitric Oxide Effect on Brain and Kidney in Pediatric Patients Undergoing Cardiopulmonary Bypass

NCT03047343CompletedPrimary

Evolution of Two Cohorts of Children (Univentricular and Bi-ventricular Heart) After Strapping of the Pulmonary Artery

Showing all 3 trials

Research Network

Common Treatments

  • Heart Will Be Treated With Custodioln1
  • Nitric Oxide No 20 Part Per Million Ppm1
  • Heart Will Be Treated With Custodiol1
  • Standard Of Care Cardiopulmonary Bypass1
  • Retrospective Data Extraction In Medical Files1

Active Sponsors

  • Dr. F. Köhler Chemie GmbH1
  • Dr. Franz Koehler Chemie GmbH1
  • Pierre Wauthy1
  • Vanderbilt University Medical Center1

Top Investigators

Related Conditions

  • Congenital Heart Malformation Inchildren1
  • Congenital Heart Defect1
  • Congenital Heart Disease1

Activity Timeline